CLRB stock

Finance

why Cellectar Biosciences Inc [CLRB] is a Good Choice for Investors After New Price Target of $5.67

Cellectar Biosciences Inc [NASDAQ: CLRB] traded at a low on Thursday, posting a -5.37 loss after which it closed the day’ session at $0.30. The results of the trading session contributed to over 12923623 shares changing hands. Over the past one week, the price volatility

Companies

Cellectar Biosciences Inc [CLRB] Is Currently -0.18 below its 200 Period Moving Avg: What Does This Mean?

Cellectar Biosciences Inc [NASDAQ: CLRB] price plunged by -0.18 percent to reach at $0.0. The one-year CLRB stock forecast points to a potential upside of 95.06. The average equity rating for CLRB stock is currently 1.50, trading closer to a bullish pattern in the stock

CLRB stock

why Cellectar Biosciences Inc [CLRB] is a Good Choice for Investors After New Price Target of $5.67

Cellectar Biosciences Inc [CLRB] Is Currently -0.18 below its 200 Period Moving Avg: What Does This Mean?

Quick Links

Categories

Get The Best Stocks To Trade Every Day!